FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A ...
18F-FluorThanatrace (18F-FTT) positron emission tomography (PET/CT) in prostate cancer measures in vivo PARP-1 expression and is associated with adverse clinicopathologic features. This is an ASCO ...
Only one retroperitoneal sarcoma (RPS) patient out of 22 achieved meaningful tumor shrinkage with pre-surgical radiation, while over 75% of the sample saw no significant change and 18% experienced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results